University Hospital Southampton is implementing Aiforia’s PD-L1 lung cancer AI solution to assess PD-L1 staining in lung cancer specimens. Dr Vipul Foria and Dr Victoria Elliot describe their journey so far.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
Charlotte Coates, Peter G. Kevan & Saira Espinosa from the University of Guelph, explore how apivectoring is innovating agricultural systems with its method of precision biological control.
We spoke with Professor Colin Jones, project coordinator of CRESCENDO, about the project’s work in predicting global climate change over the coming century.
Richie Kohman, Synthetic Biology Platform Lead at Wyss Institute at Harvard, explains the use of next-generation sequencing to analyse biological tissues in a spatially resolved context.
Associate Professor Nikolaos P. Ventikos tells us about the MOSES research and innovation project, illustrating its contribution to sustainable European Short Sea Shipping (SSS) cargo transport.
Sean E. Lawler PhD from Brigham and Women’s Hospital, Harvard Medical School, sheds light on overcoming the barriers when it comes to brain cancer therapeutics.
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
Lesley Youren, Hospital Segment Marketing Manager at Draeger Medical UK, talks about creating care-centred workplaces and improving staff satisfaction during a global pandemic.
We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.
